309
Participants
Start Date
June 30, 2012
Primary Completion Date
February 28, 2013
Study Completion Date
February 28, 2013
SIIL LAIV (live, trivalent seasonal influenza vaccine)
Dose: 0.5 mL, The viral strains in seasonal trivalent influenza vaccine (human, live attenuated) are antigenically similar to A/California/7/2009 (H1N1), A/Perth/16/2009 (H3N2) and B/Brisbane/60/2008 Type B, as per the WHO recommended strains for the Northern hemisphere 2011-12 influenza season
Placebo
Inactive placebo will be identical to SII LAIV in appearance, ingredients, and concentrations, except it will be missing attenuated influenza virus.
ICDDR,B Kamalapur, Dhaka
Johns Hopkins Bloomberg School of Public Health
OTHER
International Centre for Diarrhoeal Disease Research, Bangladesh
OTHER
PATH Vaccine Solutions
OTHER